Monday, April 20, 2015

Investigational personalized cellular therapy tolerated well by patients with advanced mesothelioma, ovarian and pancreatic cancers

Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers. The data adds to a growing body of research showing the promise of CAR T cell technology.



from Top Health News – ScienceDaily http://bit.ly/1DDC1dw via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1bkQsKq

No comments:

Post a Comment